Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.biomaterials.2013.03.029
Title: Targeting CCL21-folic acid-upconversion nanoparticles conjugates to folate receptor-α expressing tumor cells in an endothelial-tumor cell bilayer model
Authors: Lee, K.Y.
Seow, E.
Zhang, Y. 
Lim, Y.C.
Keywords: Chemokine
Endothelial-tumor cell bilayer
Folate-conjugate
T cell migration
Upconversion nanoparticles
Issue Date: Jul-2013
Citation: Lee, K.Y., Seow, E., Zhang, Y., Lim, Y.C. (2013-07). Targeting CCL21-folic acid-upconversion nanoparticles conjugates to folate receptor-α expressing tumor cells in an endothelial-tumor cell bilayer model. Biomaterials 34 (20) : 4860-4871. ScholarBank@NUS Repository. https://doi.org/10.1016/j.biomaterials.2013.03.029
Abstract: The ability of some malignant cells to evade immunosurveillance has been a major contribution to the inability of the host's immune system to eradicate the neoplastic cells. This has led to the development of various immunological strategies to augment the host immune response as part of cancer treatment. In this study, we developed folic acid (FA)/secondary lymphoid tissue chemokine (CCL21)/upconversion fluorescent nanoparticles (UCNs) conjugates as a targeting and delivery system to attract immune cells to folate receptor (FR) expressing tumor cells. Our data show that FA-conjugated UCNs@mesoporous silica specifically target FR expressing ovarian carcinoma cell line, OVCAR-3, compared to the unconjugated mesoporous silica coated UCNs. Furthermore, the FA-UCNs@mesoporous silica can efficiently cross the endothelial cell monolayer and accumulate in the clusters of OVCAR-3 cells in our endothelial-tumor cell bilayer model. Our migration assay data suggest that the CCL21 loaded into the mesoporous layer is biologically active and can efficiently induce T cells migration in-vitro. No significant cytotoxic effect was observed throughout the study indicating good biocompatibility of the nanoconjugates. As proof-of-concept, we have shown that it is feasible to load biologically active chemokines onto UCNs to modulate T cell migration. © 2013 Elsevier Ltd.
Source Title: Biomaterials
URI: http://scholarbank.nus.edu.sg/handle/10635/88156
ISSN: 01429612
DOI: 10.1016/j.biomaterials.2013.03.029
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

29
checked on Oct 9, 2018

WEB OF SCIENCETM
Citations

27
checked on Oct 9, 2018

Page view(s)

50
checked on Oct 5, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.